Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-007961
Filing Date
2023-05-04
Accepted
2023-05-04 06:30:41
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ispc-20230331x10q.htm   iXBRL 10-Q 1253127
2 EX-31.1 ispc-20230331xex31d1.htm EX-31.1 15630
3 EX-31.2 ispc-20230331xex31d2.htm EX-31.2 14890
4 EX-32.1 ispc-20230331xex32d1.htm EX-32.1 7658
  Complete submission text file 0001558370-23-007961.txt   5550425

Data Files

Seq Description Document Type Size
5 EX-101.SCH ispc-20230331.xsd EX-101.SCH 40314
6 EX-101.CAL ispc-20230331_cal.xml EX-101.CAL 39063
7 EX-101.DEF ispc-20230331_def.xml EX-101.DEF 151160
8 EX-101.LAB ispc-20230331_lab.xml EX-101.LAB 382338
9 EX-101.PRE ispc-20230331_pre.xml EX-101.PRE 292959
63 EXTRACTED XBRL INSTANCE DOCUMENT ispc-20230331x10q_htm.xml XML 874799
Mailing Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420
Business Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40501 | Film No.: 23886283
SIC: 8731 Services-Commercial Physical & Biological Research